Empagliflozin restores chronic kidney disease–induced impairment of endothelial regulation of cardiomyocyte relaxation and contraction-Reference-Cited by-同舟云学术

Empagliflozin restores chronic kidney disease–induced impairment of endothelial regulation of cardiomyocyte relaxation and contraction

Published:2021-05 Issue:5 Volume:99 Page:1088-1101
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Juni Rio P.,Al-Shama Rushd,Kuster Diederik W.D.,van der Velden Jolanda,Hamer Henrike M.,Vervloet Marc G.,Eringa Etto C.,Koolwijk Pieter,van Hinsbergh Victor W.M.

Publisher

Elsevier BV

Subject

Nephrology

Reference77 articles.

1. Association of chronic kidney disease with preserved ejection fraction heart failure is independent of baseline cardiac function;Mavrakanas;Kidney Blood Press Res,2019

2. Renal dysfunction in heart failure with a preserved ejection fraction: cause or consequence?;Ter Maaten;Eur J Heart Fail,2016

3. Association of chronic kidney disease with abnormal cardiac mechanics and adverse outcomes in patients with heart failure and preserved ejection fraction;Unger;Eur J Heart Fail,2016

4. Chronic kidney disease induces left ventricular overexpression of the pro-hypertrophic microRNA-212;Sarkozy;Sci Rep,2019

5. Osteopontin promotes left ventricular diastolic dysfunction through a mitochondrial pathway;Yousefi;J Am Coll Cardiol,2019

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of mitochondria in reno-cardiac diseases: A study of bioenergetics, biogenesis, and GSH signaling in disease transition;Redox Biology;2024-10

2. Biology of the proximal tubule in body homeostasis and kidney disease;Nephrology Dialysis Transplantation;2024-07-26

3. Endothelial Protection by Sodium-Glucose Cotransporter 2 Inhibitors: A Literature Review of In Vitro and In Vivo Studies;International Journal of Molecular Sciences;2024-07-02

4. Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis;The Lancet Diabetes & Endocrinology;2024-07

5. Is There a Role for SGLT2 Inhibitors in Patients with End-Stage Kidney Disease?;Current Hypertension Reports;2024-06-24